Modern drugs for obesity and type 2 diabetes are based on a simple insight: metabolic pathways are not controlled by a single signal, but by many acting together. Prof. Timo D. Müller is Director of the Institute for Diabetes and Obesity (IDO) at…
Mehr erfahren